LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.76
EUR
-0.02
EUR
-0.81 %
10:03:31
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.36 USD | 0.01 USD | 0.41 % |
|---|
| Vortag | 3.34 USD | Datum | 15.07.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 44.69% | |
| 21Shares Ondo ETP | CH1396389921 | 35.30% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 33.74% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 33.71% | |
| 21Shares Pendle ETP | CH1495416997 | 10.22% | |
| 21shares Gram Staking ETP | CH1297762812 | 10.06% | |
| 21Shares Stellar ETP | CH1109575535 | 5.48% | |
| 21Shares Jupiter ETP | CH1480821383 | 2.91% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -11.53% | |
| 21Shares XDC Network ETP | CH1464217285 | -13.44% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 140.37% | |
| 21shares Morpho ETP | CH1506167027 | 49.65% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 9.60% | |
| 21Shares Ondo ETP | CH1396389921 | -0.80% | |
| 21shares Canton Network ETP | CH1503127917 | -1.30% | |
| 21Shares Injective Staking ETP | CH1360612134 | -1.46% | |
| 21Shares Jupiter ETP | CH1480821383 | -9.68% | |
| 21Shares Pendle ETP | CH1495416997 | -26.90% | |
| 21Shares Bittensor ETP | CH1495416971 | -29.42% | |
| 21Shares XDC Network ETP | CH1464217285 | -36.66% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -6.11% | |
| 21Shares Binance BNB ETP | CH0496454155 | -26.76% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -33.59% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -46.57% | |
| 21Shares Bitcoin Ethereum Core ETP | CH0496484640 | -47.27% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -52.29% | |
| 21Shares Injective Staking ETP | CH1360612134 | -64.94% | |
| 21Shares XDC Network ETP | CH1464217285 | -67.41% | |
| 21Shares Dogecoin ETP | CH1431521033 | -71.21% | |
| 21Shares Sui Staking ETP | CH1360612159 | -81.43% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 79.22% | |
| 21Shares Stellar ETP | CH1109575535 | 71.72% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 41.20% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 10.75% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -1.53% | |
| 21Shares Sui Staking ETP | CH1360612159 | -14.41% | |
| 21Shares Injective Staking ETP | CH1360612134 | -81.18% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 911’116.72 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 17.07.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 60.58 | |
| Performance 2 Jahre | 45.19 | |
| Performance 3 Jahre | 9.32 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |